Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Short-term Investments (2020 - 2025)

Historic Short-term Investments for 10x Genomics (TXG) over the last 6 years, with Q4 2025 value amounting to $49.4 million.

  • 10x Genomics' Short-term Investments rose 21.89% to $49.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $49.4 million, marking a year-over-year increase of 21.89%. This contributed to the annual value of $49.4 million for FY2025, which is 21.89% up from last year.
  • According to the latest figures from Q4 2025, 10x Genomics' Short-term Investments is $49.4 million, which was up 21.89% from $49.6 million recorded in Q3 2025.
  • 10x Genomics' 5-year Short-term Investments high stood at $226.8 million for Q1 2022, and its period low was $28000.0 during Q3 2021.
  • Moreover, its 5-year median value for Short-term Investments was $49.4 million (2025), whereas its average is $74.2 million.
  • In the last 5 years, 10x Genomics' Short-term Investments crashed by 9995.29% in 2021 and then soared by 78002500.0% in 2022.
  • 10x Genomics' Short-term Investments (Quarter) stood at $1.0 million in 2021, then soared by 20351.17% to $210.2 million in 2022, then crashed by 86.01% to $29.4 million in 2023, then skyrocketed by 67.74% to $49.3 million in 2024, then increased by 0.22% to $49.4 million in 2025.
  • Its Short-term Investments was $49.4 million in Q4 2025, compared to $49.6 million in Q3 2025 and $49.5 million in Q2 2025.